TXG 10x Genomics, Inc. stock chart & analysis

Conviction 36IndustrialsScan · Fri, Nov 6, 2026

10x Genomics, Inc. (TXG) closed at $59.28 (+2.10%) on Nov 6, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 39, RS Rating 99, -42.3% from its 52-week high, +263.7% year to date. Sector: Industrials · Laboratory Analytical Instruments.

TXG$59.28+2.10%

ResistanceSupportVol 14Insider sell

Loading chart…

10x Genomics, Inc.Laboratory Analytical Instrumentswww.10xgenomics.com ↗

Price59.28

Change+2.10%

Gap-0.98%

Rel volume1.54×

Avg volume3.64M

Avg $ vol254.23M

SMA 2070.93

SMA 5073.95

SMA 20041.58

Price vs 50-19.79%

Price vs 200+42.65%

MA stackmixed

50/200 cross—

Supertrenddown · 80.39

RSI (14)39

MACD hist-1.85

MACD crossbear · 5d

Stoch %K / %D11 / 13

ADX (14)21

+DI / −DI19 / 30

RSI divergence—

MACD divergence—

ATR %11.83%

ADR %8.79%

52w high102.81

52w low12.80

From 52w high-42.30%

Above 52w low+363.44%

New 52w highNo

SqueezeOff

Bollinger width35.91%

%B0.04

Donchian pos11.38%

Donchian high87.82

Donchian low55.66

AVWAP (52w high)73.08

vs AVWAP high-18.83%

AVWAP (52w low)39.25

vs AVWAP low+51.15%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d1.54×

Avg vol (14d)3.59M

Avg vol (20d)3.64M

Avg $ vol (20d)254.23M

Market cap7.57B

RS Rating99 / 99

RS 3m (vs SPY)+6.15%

RS 6m (vs SPY)+174.93%

RS line new highNo

Trend template6/8

Technical rank66.5

1 week-15.39%

1 month-23.24%

3 months+1.28%

6 months+174.63%

1 year+339.73%

YTD+263.70%

P/E-173.95

P/B9.04

P/S11.78

P/FCF58.22

EPS-0.3500

Div yield—

ROE-5.20%

ROA-4.10%

Debt/Eq0.00

Current5.12

EV/EBITDA-284.37

Gross margin69.05%

Net margin-6.77%

Rev growth5.25%

EPS growth76.16%

Price target73.47

Target upside23.85%

Analyst ratingHold

Institutional117.63%

Ent. value7.05B

Revenue150.67M

Net income-19.43M

Gross profit112.93M

Free cash flow130.12M

IndustryLaboratory Analytical Instruments

ExchangeNasdaq

Shares out116.88M

Employees1.18K

ListedThu, Sep 12, 2019

Free float113.98M

Float %96.9%

Short interest—

Days to cover—

Short volume26.4%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est−$0.15 vs −$0.29

Last surprise+48.3% beat

Setup gradeD

Conviction36 / 100

Pattern quality—

Tech rank66.5 / 100

Group rank32 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance98.99

Support64.25

Days since event—

Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

TXG technical analysis

Trend

TXG's moving averages are mixed — no clean uptrend or downtrend. It closed 19.8% below the 50-day ($73.95) and 42.6% above the 200-day ($41.58). ADX(14) at 21 points to a moderate trend. It meets 6 of 8 trend-template criteria.

Momentum

RSI(14) is 39, in the bearish half of its range. MACD crossed below its signal line 5 sessions ago. Its RS Rating of 99 puts its weighted 12-month performance ahead of about 99% of the US market.

Volume and volatility

Volume on the latest session ran 1.5× its 20-day average. It trades about $254.2M a day on average. ATR(14) is $7.02, 11.8% of price — its typical daily range.

Key levels

The chart pattern's support is $64.25 and its resistance $98.99. The 52-week range is $12.80 to $102.81; price is 42.3% below the high and 363.4% above the low. The VWAP anchored at the 52-week high is $73.08, above price.

Performance

TXG returned -15.4% (1 week), -23.2% (1 month), +1.3% (3 months), +174.6% (6 months), +339.7% (1 year), +263.7% (year to date).

About 10x Genomics, Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Laboratory Analytical Instruments · Listed 2019 · 1,178 employees

Insider activity

SEC Form 4 transactions in TXG · open-market 10 sells

Insider	Side	Shares	Value	Traded	Filed
Taich Adam Chief Financial Officer · Class A Common Stock · 2026-09-09	Sell	1.21K	$77K	2026-09-09	2026-09-11
Taich Adam Chief Financial Officer · Class A Common Stock · 2026-09-09	Sell	31.43K	$2.0M	2026-09-09	2026-09-11
Taich Adam Chief Financial Officer · Class A Common Stock · 2026-09-09	Sell	13.75K	$898K	2026-09-09	2026-09-11
STUELPNAGEL JOHN R Director · Class A Common Stock · 2026-09-03	Sell	7.01K	$425K	2026-09-03	2026-09-08
STUELPNAGEL JOHN R Director · Class A Common Stock · 2026-09-03	Sell	6.81K	$423K	2026-09-03	2026-09-08
STUELPNAGEL JOHN R Director · Class A Common Stock · 2026-09-03	Sell	6.17K	$387K	2026-09-03	2026-09-08
Saxonov Serge Chief Executive Officer · Class A Common Stock · 2026-08-26	Sell	3.5K	$221K	2026-08-26	2026-08-28
Saxonov Serge Chief Executive Officer · Class A Common Stock · 2026-08-26	Sell	6.49K	$415K	2026-08-26	2026-08-28
Saxonov Serge Chief Executive Officer · Class A Common Stock · 2026-08-26	Sell	492	$32K	2026-08-26	2026-08-28
Hindson Benjamin J. See Remarks · Class A Common Stock · 2026-08-24	Sell	13.82K	$871K	2026-08-24	2026-08-26

SEC filings

EDGAR filings in TXG · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.